Find your next paid study

Boston Children's HospitalNCT04380740

~$75 – $2,000

Actual pay is set by the research site.

Sexual and Gender MinoritiesHospiceAlzheimer's Disease and Related Dementias

A Novel Intervention to Improve Care for Older Sexual and Gender Minority (SGM) Adults With Serious Illness and Especially Those With Alzheimer's Disease and Related Dementias (ADRD)

Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (A…

University of Colorado, DenverNCT05877391

Actual pay is set by the research site.

GingivitisGingival BleedingDental Plaque

Evaluation of the Safety and Efficacy of Adjunctive Use of Flaus Electric Flosser and a Manual Toothbrush in Reducing Plaque and Gingivitis: A 30-Day Randomized, Parallel, Controlled Clinical Study

The purpose of this study to evaluate the safety and efficacy of an electric flosser (interproximal cleaning aid), when used with a manual toothbrush and fluor…

Advanced Solid CancerMetastatic Solid Cancer

~$10 – $1,050

Actual pay is set by the research site.

Flaus, IncNCT07805148

Phase 1

A First-in-human Phase I, Open-label, Multicentre, Dose Escalation Trial of BI 3819026 in Combination With Ezabenlimab in Patients With Unresectable Advanced or Metastatic Solid Cancers to Determine the Maximum Tolerated Dose (MTD) and Recommended Dose for Expansion (RDE)

This study is open to adults with advanced cancer. The purpose of this study is to find the highest dose of BI 3819026 that people with advanced cancer can tol…

Boehringer IngelheimNCT07607678

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CT

This phase I trial studies how well fluorine F 18 fluorthanatrace positron emission tomography (PET)/computed tomography (CT) works in patients with solid tumo…

Breast CarcinomaFallopian Tube CarcinomaOvarian Carcinoma+5 more

M.D. Anderson Cancer CenterNCT03604315

~$150 – $3,000

Actual pay is set by the research site.

Fuchs Endothelial Corneal DystrophyCorneal Endothelial Decompensation

Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success

This multi-center clinical trial is designed to assess the association of diabetes in a cornea donor with transplant success and loss of endothelial cells 5 ye…

Case Western Reserve UniversityNCT07217249

Actual pay is set by the research site.

Phase 2

Human Penile Allotransplantation

Injuries to the genitalia are of concern to the military with emphasis placed on the surgical reconstruction and psychological health of these Wounded Warriors…

AmputationWounds and InjuriesAmputation, Traumatic+6 more

Johns Hopkins UniversityNCT02395497

~$75 – $2,000

Actual pay is set by the research site.

Interactive Virtual Occupational Safety Training Designed With and for Ohio Home Healthcare Workers and Agencies

Overview. The investigators will collect preliminary data on the extent to which the knowledge gained from the enhanced HH-VSTS transfers to a real-world envir…

Learning

Ohio State UniversityNCT06974708

Actual pay is set by the research site.

Early Detection of Pancreatic Cancer: Prospective Study

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more

City of Hope Medical CenterNCT06388967

Actual pay is set by the research site.

Phase 1

A Phase 1, Multicentre, Open-label, Multiple-dose Study to Determine Safety, Tolerability, and Preliminary Efficacy of SBO-154 in Subjects With Advanced Solid Tumors

This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available …

Advanced Solid Tumors

Sun Pharma Advanced Research Company LimitedNCT07042100

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia

The main objective of the study is to evaluate NBI-1117568 compared with placebo in delaying relapse of symptoms of schizophrenia in adults who have a stable r…

Schizophrenia

Neurocrine BiosciencesNCT07227818

~$50 – $2,100

Actual pay is set by the research site.

Retraining Reaching in Cerebellar Ataxia

The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving reaching movements…

Cerebellar Ataxia